Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron as add-on therapy in sepsis patients with iron deficiency anemia
TCTR20250407003Phase 4Not yet recruiting
- Sponsor
- Thammasat University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Iron in sepsis, iron deficiency anemia (IDA), sponsored by Thammasat University. Planned start May 2025; status: not yet recruiting.
02
Drugs
Iron
03
Conditions
sepsisiron deficiency anemia (IDA)
Beyond the preview
Go deeper on TCTR20250407003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250407003.